ZacharyCurryMDPhD

Pain Medicine

Pain Medicine Fellow at MGH

Dr. Curry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am passionate about helping those with chronic pain and functional limitations accomplish their life goals.
My research interests are in pain management including outcomes in patients with pain and pain pharmacology.

Spaulding Rehabilitation Hospital/Harvard Medical SchoolResidency, Physical Medicine and Rehabilitation, 2021 - 2024
Virginia Commonwealth University Health SystemInternship, Internal Medicine, 2020 - 2021
Virginia Commonwealth University School of MedicineClass of 2020, MD
Virginia Commonwealth University School of MedicinePhD, Pharmacology and Toxicology, 2012 - 2020
Winthrop UniversityBachelor of Science, Chemistry (Biochemistry) with minors in Biology & Mathematics, Summa Cum Laude, 2012

Travel Award for Oral Presentation International Cannabinoid Research Society Symposium - Montreal, Quebec, 2017
NIH Training Grant Support (Training in The Pharmacology of Abused Drugs) Department of Pharmacology & Toxicology, VCU, 2016-2017
Diversity Travel Award National MD/PhD Student Conference - Keystone, CO, 2016
First Place, Best Basic Science Paper St. Jude Children's Research Hospital Pediatric Oncology Education (POE) Program, 2010
Join now to see all

PubMed

8 citations
Combination therapy with methadone and duloxetine for cancer-related pain: a retrospective study
Zachary A Curry, Malisa C Dang, Adam Sima, Sura Abdullaziz, Egidio Del Fabbro
Annals of Palliative Medicine. 2021-01-19
110 citations
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
Giulia Donvito, Sara R. Nass, Jenny L. Wilkerson, Zachary A Curry, Lesley D. Schurman
Neuropsychopharmacology. 2018-01-01
55 citations
Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.
Zachary A Curry, Jenny L. Wilkerson, Deniz Bagdas, S. Lauren Kyte, Nipa H. Patel
The Journal of Pharmacology and Experimental Therapeutics. 2018-01-01

Abstracts/Posters

Pain is widespread in inpatient rehabilitation patients across impairment types
Curry ZA, Andrew MN, Chiang MC, Goldstein R, Ryan CM, Schneider JC, Physiatry '23 (annual meeting of Association of Academic Physiatrists), Anaheim, CA, 2/2023
Monoacylglycerol Lipase: A novel target for paclitaxel-induced peripheral neuropathy
Curry ZA and Lichtman AH, National MD/PhD Student Conference, Keystone, CO, 2017
The MAGL inhibitor JZL184 prevents the development of paclitaxel-induced mechanical allodynia
Curry ZA, Toma W, Meade JA, Wilkerson JL, Damaj MI, Lichtman AH, Oral presentation. Carolina Cannabinoid Collaborative Conference. Presented in absentia., Durham, NC, 2017
Monoacylglycerol lipase inhibitors: reversal of mouse paclitaxel-induced nociception without intrinsic reinforcing effects
Curry ZA, Wilkerson JL, Bagdas D, Damaj MI, Lichtman AH, Oral presentation. International Cannabinoid Research Society Symposium on the Cannabinoids, Montreal, Quebec, 2017
Monoacylglycerol lipase inhibitors produce antinociception through cannabinoid receptor 1- and 2-dependent manners in the mouse paclitaxel model of chemotherapy-induce...
Curry ZA and Lichtman AH, American Physician Scientists Association National Conference, Chicago, IL, 2017
Join now to see all